Parallel evaluation of circulating tumor DNA and circulating tumor cells in metastatic colorectal cancer.
Authors
Germano, GMauri, G
Siravegna, G
Dive, Caroline
Pierce, Jackie
Di Nicolantonio, F
D'Incalci, M
Bardelli, A
Siena, S
Sartore-Bianchi, A
Affiliation
Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO), ItalyIssue Date
2017-11-01
Metadata
Show full item recordAbstract
Tissue biopsy is the gold standard for tumor genotyping, but it is an invasive procedure providing a single snapshot into tumor heterogeneity. Liquid biopsy approaches, encompassing the analysis of circulating tumor DNA (ctDNA) or circulating tumor cells (CTCs), have been proposed as an alternative, with the potential of providing a comprehensive portrait of the tumor molecular landscape. In metastatic colorectal cancer (mCRC), both CTCs and ctDNA analysis have been investigated, but comparative analyses are limited.Citation
Parallel evaluation of circulating tumor DNA and circulating tumor cells in metastatic colorectal cancer. 2017, Clin Colorectal CancerJournal
Clinical Colorectal CancerDOI
10.1016/j.clcc.2017.10.017PubMed ID
29195807Type
ArticleLanguage
enISSN
1938-0674ae974a485f413a2113503eed53cd6c53
10.1016/j.clcc.2017.10.017
Scopus Count
Collections
Related articles
- Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer.
- Authors: Kidess-Sigal E, Liu HE, Triboulet MM, Che J, Ramani VC, Visser BC, Poultsides GA, Longacre TA, Marziali A, Vysotskaia V, Wiggin M, Heirich K, Hanft V, Keilholz U, Tinhofer I, Norton JA, Lee M, Sollier-Christen E, Jeffrey SS
- Issue date: 2016 Dec 20
- Significance of postoperative follow-up of patients with metastatic colorectal cancer using circulating tumor DNA.
- Authors: Benešová L, Hálková T, Ptáčková R, Semyakina A, Menclová K, Pudil J, Ryska M, Levý M, Šimša J, Pazdírek F, Hoch J, Blaha M, Minárik M
- Issue date: 2019 Dec 28
- Liquid Biopsy for the Management of Patients with Colorectal Cancer.
- Authors: Yamada T, Matsuda A, Koizumi M, Shinji S, Takahashi G, Iwai T, Takeda K, Ueda K, Yokoyama Y, Hara K, Hotta M, Matsumoto S, Yoshida H
- Issue date: 2019
- Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial.
- Authors: Bidard FC, Kiavue N, Ychou M, Cabel L, Stern MH, Madic J, Saliou A, Rampanou A, Decraene C, Bouché O, Rivoire M, Ghiringhelli F, Francois E, Guimbaud R, Mineur L, Khemissa-Akouz F, Mazard T, Moussata D, Proudhon C, Pierga JY, Stanbury T, Thézenas S, Mariani P
- Issue date: 2019 May 28
- Clinical utility of comprehensive circulating tumor DNA genotyping compared with standard of care tissue testing in patients with newly diagnosed metastatic colorectal cancer.
- Authors: Benavides M, Alcaide-Garcia J, Torres E, Gil-Calle S, Sevilla I, Wolman R, Durán G, Álvarez M, Reyna-Fortes C, Ales I, Pereda T, Robles M, Kushnir M, Odegaard J, Faull I, Alba E
- Issue date: 2022 Jun